Total Visits

Views
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 88

Total Visits Per Month

March 2020April 2020May 2020June 2020July 2020August 2020September 2020
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 38 2 2 4 2 2 1

Top country views

Views
United States 40
China 31
Qatar 7
Germany 3
United Kingdom 1
Netherlands 1

Top cities views

Views
Zhengzhou 14
Ashburn 12
Shanghai 8
Ann Arbor 7
Fairfield 5
Jinan 5
Shenzhen 4
Encino 2
Houston 2
Mountain View 2